Biolexis Therapeutics Inc.
Biotechnology company · Lehi, Utah, United States
Biolexis Therapeutics Inc. is a biotechnology company headquartered in Lehi, Utah, United States. Its earliest recorded incorporation is in 2021. It has reported private securities offerings to the US SEC, most recently $1.6 million sold in a notice filed in 2026.
Biolexis Therapeutics at a glance
What does Biolexis Therapeutics do?
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $1.6 million sold (2026).
Frequently asked questions about Biolexis Therapeutics
Where is Biolexis Therapeutics headquartered?
Biolexis Therapeutics Inc. is headquartered in Lehi, Utah, United States.
What does Biolexis Therapeutics do?
Biolexis Therapeutics Inc. is a biotechnology company.
When was Biolexis Therapeutics founded?
The earliest incorporation on record for Biolexis Therapeutics Inc. is in 2021, according to public company registers.
Similar companies
- Photopharmics IncLehi, Utah, United States
- Halia Therapeutics, Inc.Lehi, Utah, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences